Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 82

1.

A double-edged sword in B-cell-targeted therapy for inflammatory diseases.

Mizuguchi J.

Expert Rev Clin Immunol. 2009 May;5(3):283-90. doi: 10.1586/eci.09.11.

PMID:
20477006
[PubMed]
2.

B-cell-targeted therapy for systemic lupus erythematosus.

Sabahi R, Anolik JH.

Drugs. 2006;66(15):1933-48.

PMID:
17100405
[PubMed - indexed for MEDLINE]
3.

B- and T-lymphocytes in ocular disease.

Jakobiec FA, Lefkowitch J, Knowles DM 2nd.

Ophthalmology. 1984 Jun;91(6):635-54.

PMID:
6235470
[PubMed - indexed for MEDLINE]
4.

Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs.

Ganea D.

Adv Neuroimmunol. 1996;6(1):61-74. Review.

PMID:
8790782
[PubMed - indexed for MEDLINE]
5.

[B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].

Kondo S, Akashi T, Katsuta H, Iwakiri R, Anzai K, Nagafuchi S, Niho Y, Harada M.

Fukuoka Igaku Zasshi. 2005 Apr;96(4):86-92. Review. Japanese.

PMID:
15991605
[PubMed - indexed for MEDLINE]
6.

Cooperation of liver cells in health and disease.

Kmieć Z.

Adv Anat Embryol Cell Biol. 2001;161:III-XIII, 1-151. Review.

PMID:
11729749
[PubMed - indexed for MEDLINE]
7.

Dendritic cell gene therapy.

Onaitis M, Kalady MF, Pruitt S, Tyler DS.

Surg Oncol Clin N Am. 2002 Jul;11(3):645-60. Review.

PMID:
12487060
[PubMed - indexed for MEDLINE]
8.

Effects of specific anti-B and/or anti-plasma cell immunotherapy on antibody production in baboons: depletion of CD20- and CD22-positive B cells does not result in significantly decreased production of anti-alphaGal antibody.

Alwayn IP, Xu Y, Basker M, Wu C, Buhler L, Lambrigts D, Treter S, Harper D, Kitamura H, Vitetta ES, Abraham S, Awwad M, White-Scharf ME, Sachs DH, Thall A, Cooper DK.

Xenotransplantation. 2001 Aug;8(3):157-71.

PMID:
11472623
[PubMed - indexed for MEDLINE]
9.

Targeting B cells in immune-mediated inflammatory disease: a comprehensive review of mechanisms of action and identification of biomarkers.

Dörner T, Kinnman N, Tak PP.

Pharmacol Ther. 2010 Mar;125(3):464-75. doi: 10.1016/j.pharmthera.2010.01.001. Epub 2010 Jan 25. Review.

PMID:
20097226
[PubMed - indexed for MEDLINE]
10.

Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer.

Jasani B, Navabi H, Adams M.

Vaccine. 2009 May 26;27(25-26):3401-4. doi: 10.1016/j.vaccine.2009.01.071. Epub 2009 Feb 5.

PMID:
19200817
[PubMed - indexed for MEDLINE]
11.

Lowering anti-dsDNA antibodies--what's new?

Schiffer LE, Hussain N, Wang X, Huang W, Sinha J, Ramanujam M, Davidson A.

Lupus. 2002;11(12):885-94. Review.

PMID:
12529055
[PubMed - indexed for MEDLINE]
12.

Defining the ability of cyclophosphamide preconditioning to enhance the antigen-specific CD8+ T-cell response to peptide vaccination: creation of a beneficial host microenvironment involving type I IFNs and myeloid cells.

Salem ML, Kadima AN, El-Naggar SA, Rubinstein MP, Chen Y, Gillanders WE, Cole DJ.

J Immunother. 2007 Jan;30(1):40-53.

PMID:
17198082
[PubMed - indexed for MEDLINE]
13.

Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection.

Coutinho A, Caramalho I, Seixas E, Demengeot J.

Curr Top Microbiol Immunol. 2005;293:43-71. Review.

PMID:
15981475
[PubMed - indexed for MEDLINE]
15.

The role of T-cell-mediated mechanisms in virus infections of the nervous system.

Dörries R.

Curr Top Microbiol Immunol. 2001;253:219-45. Review.

PMID:
11417137
[PubMed - indexed for MEDLINE]
16.

Clinical applications of rituximab in allogeneic stem cell transplantation: anti-tumor and immunomodulatory effects.

Ratanatharathorn V, Pavletic S, Uberti JP.

Cancer Treat Rev. 2009 Dec;35(8):653-61. doi: 10.1016/j.ctrv.2009.07.004. Epub 2009 Aug 13. Review.

PMID:
19682801
[PubMed - indexed for MEDLINE]
17.

Effects of leflunomide and deoxyspergualin in the guinea pig-->rat cardiac model of delayed xenograft rejection: suppression of B cell and C-C chemokine responses but not induction of macrophage lectin.

Hancock WW, Miyatake T, Koyamada N, Kut JP, Soares M, Russell ME, Bach FH, Sayegh MH.

Transplantation. 1997 Sep 15;64(5):696-704. Erratum in: Transplantation 1997 Oct 27;64(8):1225.

PMID:
9311705
[PubMed - indexed for MEDLINE]
18.

Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).

Gattoni A, Parlato A, Vangieri B, Bresciani M, Derna R.

Clin Ter. 2006 Jul-Aug;157(4):377-86. Review. Retraction in: Clin Ter. 2008 May-Jun;159(3):207.

PMID:
17051976
[PubMed - indexed for MEDLINE]
19.

The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy.

Dammacco F, Sansonno D, Piccoli C, Racanelli V, D'Amore FP, Lauletta G.

Semin Liver Dis. 2000;20(2):143-57. Review.

PMID:
10946420
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk